Issued Patents All Time
Showing 1–16 of 16 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12390464 | Treatment of EGFR mutant-related cancers using a combination of EGFR and CDK4/6 inhibitors | Michael N. Greco, Michael John Costanzo, Michael Alan Green, Jirong Peng | 2025-08-19 |
| 12258365 | Organophosphorus-substituted compounds as c-MET inhibitors and therapeutic uses thereof | Jirong Peng, Michael N. Greco, Michael John Costanzo, Michael Alan Green | 2025-03-25 |
| 12187707 | Pharmaceutical formulations of N-(2-(2-(dimethylamino)ethoxy)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylaminde and salts thereof | Michael N. Greco, Michael John Costanzo, Michael Alan Green, Jirong Peng, Victoria Lynn Wilde | 2025-01-07 |
| 11414401 | Substituted 2-anilinopyrimidine derivatives as EGFR modulators | Jirong Peng, Michael John Costanzo, Michael N. Greco, Michael Alan Green, Victoria Lynn Wilde | 2022-08-16 |
| 11352341 | 2H-indazole derivatives as CDK4 and CDK6 inhibitors and therapeutic uses thereof | Michael N. Greco, Michael John Costanzo, Jirong Peng | 2022-06-07 |
| 11180478 | Pharmaceutical formulations of N-(2-(2-(dimethylamino) ethoxy)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide and salts thereof | Michael N. Greco, Michael John Costanzo, Michael Alan Green, Jirong Peng, Victoria Lynn Wilde | 2021-11-23 |
| 11052086 | 2-anilinopyrimidine derivatives as therapeutic agents for treatment of brain cancers | Michael N. Greco, Michael John Costanzo, Michael Alan Green, Jirong Peng, Victoria Lynn Wilde | 2021-07-06 |
| 10844045 | Pharmaceutical salts N-(2-(2-(dimethylamino)ethoxy)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide and crystalline forms thereof | Michael N. Greco, Michael John Costanzo, Michael Alan Green, Jirong Peng, Victoria Lynn Wilde | 2020-11-24 |
| 10590111 | Substituted 2-anilinopyrimidine derivatives as EGFR modulators | Jirong Peng, Michael John Costanzo, Michael N. Greco, Michael Alan Green, Victoria Lynn Wilde | 2020-03-17 |
| 10239864 | 2-H-indazole derivatives as cyclin-dependent kinase (CDK) inhibitors and therapeutic uses thereof | Michael N. Greco, Michael John Costanzo, Jirong Peng, Victoria Lynn Wilde | 2019-03-26 |
| 9878994 | 2-H-indazole derivatives as cyclin-dependent kinase (CDK) inhibitors and therapeutic uses thereof | Michael N. Greco, Michael John Costanzo, Jirong Peng, Victoria Lynn Wilde | 2018-01-30 |
| 9820721 | Aspiration and biopsy needle apparatus and devices and applications thereof | Jirong Peng | 2017-11-21 |
| 9359370 | Icotinib hydrochloride, synthesis, crystalline forms, pharmaceutical compositions, and uses thereof | Yinxiang Wang, Guojian Xie, Lieming DING, Fenlai Tan, Yunyan Hu +6 more | 2016-06-07 |
| 9163010 | Indolinone protein kinase inhibitors | Guojian Xie | 2015-10-20 |
| 8822482 | Icotinib hydrochloride, synthesis, crystalline forms, pharmaceutical compositions, and uses thereof | Yinxiang Wang, Guojian Xie, Lieming DING, Fenlai Tan, Yunyan Hu +6 more | 2014-09-02 |
| 7078409 | Fused quinazoline derivatives useful as tyrosine kinase inhibitors | Guojian Xie, Charles Davis, Zhengzhuang Cheng, Hang Chen, Yinxiang Wang +1 more | 2006-07-18 |